Breast Cancer Drug Trial Results: 75% of Tumors Shrink in New Study
New breast cancer drug trial results show 75% tumor shrinkage. Trastuzumab rezetecan outperformed chemotherapy in the HORIZON-Breast06 study for HER2-low patien
Nvidia shocks Wall Street by delaying its routine SEC 10-Q filing amid federal probes and mounting corporate governance scrutiny. Read the full analysis.
Senator John Cornyn blocks Trump nominee T. Elliot Gaiser from a Texas federal court seat, citing lack of trial experience and local ties.
Bo French loses his elite Texas country club membership in a stunning social fallout over his polarizing political reputation and public rhetoric.
Influencer Braden E. Peters, known as Clavicular, faces new rape indictments in a 2025 Cape Cod case. Analysis of the legal shift and the looksmaxxing controver
Anduril co-founder Palmer Luckey warns that AI-powered cyberattacks are drastically outpacing outdated enterprise defenses. Read the full analysis.
Deep-dive original reporting on today's highest-velocity U.S. search queries
New breast cancer drug trial results show 75% tumor shrinkage. Trastuzumab rezetecan outperformed chemotherapy in the HORIZON-Breast06 study for HER2-low patien